Cadila Healthcare Q4 net up 11% at Rs 389 crore
In a separate filing, the company said the board has not recommended any final dividend,interim declared on March 8, will be the final dividend for the year.13-05-2016
13-05-2016
Change of Registrar and Share Transfer Agent (RTA)
Cadila Healthcare Ltd has informed BSE regarding "Change of Registrar and Share Transfer Agent (RTA)".13-05-2016
Fixes Book Closure for AGM
Cadila Healthcare Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from July 25, 2016 to August 03, 2016 (both days inclusive) for the purpose of Annual General Meeting (AGM) of the Company to be held on August 03, 2016.13-05-2016
Outcome of Board Meeting
Cadila Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 13, 2016 has considered and approved in-principle, the following fund raising proposals, which are subject to approval of the members at the ensuing Annual General Meeting :1. to issue Equity Shares / convertible Bonds through Qualified Institutional Placement [QIP] / GDR / ADR / FCCBs / FCEBs / Convertible Securities for an aggregate amount upto Rs. 10,000 Crores,...13-05-2016
Outcome of Board Meeting (Appointment of Director)
Cadila Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 13, 2016 has appointed Mr. Apurva S. Diwanji as an Additional Independent Director of the Company for a period of five years from May 13, 2016 till May 12, 2021, subject to approval of the members at the ensuing Annual General Meeting. The details of the terms of appointment are attached to this letter.13-05-2016
Results Press Release for March 31, 2016
Cadila Healthcare Ltd has informed BSE about : 1. Result Press Release for the period ended March 31, 201613-05-2016
Outcome of Board Meeting
Cadila Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 13, 2016 has not recommended final dividend on the equity shares and the interim dividend declared on March 08, 216 is the final dividend on the equity shares of the Company for the financial Year ended on March 31, 2016.13-05-2016
Announces Q4 & FY16 Results (Standalone & Consolidated), Form A (Standalone & Consolidated) & Auditors Report (Standalone & Consolidated) for the period ended March 31, 2016
Cadila Healthcare Ltd has announced the following results for the quarter & year ended March 31, 2016:The Audited Standalone results for the Quarter ended March 31, 2016The Company has posted a net profit of Rs. 3380 million for the quarter ended March 31, 2016 as compared to Rs. 3470 million for the quarter ended March 31, 2015. Total Income has increased from Rs. 14688 million for the quarter ended March 31, 2015 to Rs. 14876 million for the quarter ended March 31, 2016....13-05-2016
Post results conference call with investors / analysts
Cadila Healthcare Ltd has informed BSE regarding "Post results conference call with investors / analysts".11-05-2016